TRIAL DETAIL

Gastrointestinal Stromal Tumors (GIST) Registry

Drug:
Trial Name:
Gastrointestinal Stromal Tumors (GIST) Registry
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Completed
Phase:
Start Date 08/01/2005
Age of Trial (yrs) 19.3
Treatment Phase:
All
Drug Category:
Strategy:
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
2005-0294
Sponsor:
MD Anderson, Novartis
Patient Contact:
U.T.M.D. Anderson Cancer Center Jonathon Trent, MD, PhD
Contact email:
Contact Phone:
713-792-3626
Randomized:
IV or Oral:
Trial Notes:
The goal of this observational research study is to establish a registry of information regarding how different physicians treat and manage patients with gastrointestinal stromal tumors (GISTs). [ Time Frame: 5 Years ]

The Registry, which is Internet based, is intended to collect information about current practices in the management of GIST without making any specific change to the standard of care as decided by each patient's treating physician.

If you agree to participate in this study, your doctor will provide information to a data registry about your physical and clinical traits, the past and current medical care you have received to treat your GIST, and clinically-related, economically-related, and health-related quality of life information. About 200 doctors will provide information on their patients for the Registry. Your doctor will collect this information when you first join the Registry and at each regularly scheduled visit you make to your doctor's office. The information collection will continue for as long as you and your doctor feel it is appropriate. The information that is entered into the Registry will remain there indefinitely. It is hoped that this sharing of information will lead to a better understanding of how to best treat patients with GIST.

You and your doctor will decide what treatment you will receive. Because this Registry is only to observe actual medical practice, it does not require you to receive any particular treatment.

Only your doctor and people who will help your doctor collect the information for this Registry will know which information submitted to the Registry belongs to you. Data will be tracked in the Registry using only ID numbers and patient initials. The information submitted on the Registry data collection forms will not be associated with a specific patient's identity. Separately, you will be asked to provide your name, place of birth, and Social Security number. This information will not be entered into the Registry databases and will only be used if it is necessary to perform a search should you become lost to follow up. If you do not want to provide your Social Security number you may still be enrolled in the Registry.

This is an investigational study. About 75 patients from M. D. Anderson will be entered into the Registry. In all, about 1800 patients will be registered. The Registry will be active for at least 7 years.

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
1505 Holcombe Blvd.
Houston
TX
77030
USA